Multiple Sclerosis Brainstem Lesions: Clinical Syndromes and Symptom Spectrum
Brainstem involvement in multiple sclerosis (MS) is common (∼50% at autopsy) and produces distinctive syndromes due to dense packing of cranial nerve nuclei and long tracts.
Key Brainstem Syndromes in MS
| Syndrome | Localization | Classic Features |
|---|---|---|
| INO (Internuclear Ophthalmoplegia) | Medial longitudinal fasciculus (MLF) – pons/midbrain | Ipsilateral adduction deficit + contralateral abducting nystagmus. Convergence preserved. Bilateral in 30% MS. |
| One-and-a-half syndrome | MLF + PPRF (or CN VI nucleus) | Horizontal gaze palsy to one side + INO to the other. "Only eye moving is abducting eye on opposite side." |
| Trigeminal neuralgia (TN) | CN V root entry zone (pons) | Paroxysmal, electric-shock facial pain (V2/V3). MS-associated TN: younger, bilateral, often symptomatic (vs. vascular compression). |
| Facial palsy (CN VII) | Facial nucleus/fascicle (pons) | Lower motor neuron pattern (forehead spared in UMN). May be recurrent. |
| Dysarthria / Dysphagia | CN IX, X, XII nuclei (medulla) + corticobulbar tracts | Scanning speech, nasal regurgitation, aspiration risk. Pseudobulbar affect (emotional lability). |
| Central vertigo / nystagmus | Vestibular nuclei, cerebellar connections | Direction-changing, vertical, torsional nystagmus; not fatigueable; ± skew deviation. |
| Autonomic / Respiratory | Medullary centers | Neurogenic bladder/bowel, orthostatic hypotension, central sleep apnea, periodic breathing. |
Associated Long Tract Signs
- Corticospinal: spasticity, hyperreflexia, Babinski, weakness.
- Spinothalamic: contralateral pain/temp loss.
- Dorsal column: ipsilateral vibration/proprioception loss.
Diagnostic & Monitoring
- MRI brainstem: T2/FLAIR hyperintensities, gadolinium enhancement (active), T1 hypointensity (chronic "black holes").
- VEP, BAER, SSEP for subclinical involvement.
- EDSS heavily weighted by brainstem/cerebellar function.
Management
- DMTs (high-efficacy early: anti-CD20, S1P modulators, natalizumab) reduce new lesions.
- Symptomatic: baclofen/gabapentin (spasticity/neuropathic pain), carbamazepine/oxcarbazepine (TN), dalfampridine (walking), speech/swallow therapy, vestibular rehab.
- Multidisciplinary: neurology, urology, PT/OT/SLP, neuropsychology, palliative care.
Brainstem MS is a marker of aggressive disease. Early high-efficacy DMT and symptomatic care preserve function.
Brain & Nervous System - Related Articles
- Understanding Drug-Induced Comas in Children: Causes, Benefits & Effects
- Methyl B12 vs. Cyanocobalamin: Which Vitamin B12 Form is Best?
- Managing Drooling in Cerebral Palsy: Causes & Solutions
- Huntington's Disease: Affected Organ Systems & Symptoms
- Protect & Enhance Your Brain Health: A Comprehensive Guide
- Cat Therapy for Brain Injury Recovery: Benefits & How It Works
- Brain Regions Implicated in Autism & Asperger's Syndrome
